Prenatal and Newborn Genetic Testing Market to Grow at a CAGR of 12.2% to reach US$ 11,204.74 Mn from 2018 to 2027

    Prenatal and Newborn Genetic Testing Market to 2027 - Global Analysis and Forecasts By Product (Diagnostic, and Screening), Disease (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, and Other Disease), End User (Hospitals and Clinics, Diagnostic Centers, and Other End User) and Geography

    Publication Month: Jul 2019 | Report Code: TIPBT00002550 | No. of Pages: 194 | Category: Biotechnology | Status: Published

    The prenatal and newborn genetic testing market was valued at US$ 4,034.4 million in 2018 and it is projected to reach US$ 11,204.7 million in 2027; it is expected to grow at a CAGR of 12.2% from 2019 to 2027.

    Prenatal genetic testing is performed during the pregnancy for the diagnosis of the diseases or detection of specific genetic abnormalities before 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Most of the prenatal genetic tests use a blood sample from the mother for conduction of various screens. Diagnostic methods are more effective, accurate, and a preferred option for the detection of chromosome abnormalities as compared to the screening methods. The growth of the global prenatal and newborn genetic testing market is attributed to the increase in the prevalence of genetic diseases among infants, supportive government for promoting the use of prenatal and newborn testing and increasing birth rate. However, risk associated with prenatal genetic tests is the major factor hindering the market growth.

    The global prenatal and newborn genetic testing market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

    Lucrative Regions for Global Prenatal and Newborn Genetic Testing Market
    Lucrative Regions for Global Prenatal and Newborn Genetic Testing Market

    Get more information on this report :



    Market Insights

    High Prevalence of Genetic Diseases in Infants to Drive Global Prenatal and Newborn Genetic Testing Market Growth

    Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants. Moreover, these diseases are also responsible for infant mortality across the globe. For instance, according to the World Health Organization 2016, an estimated 7.9 million infants across world are born with genetic defects. Moreover, according to the Centers for Disease Control and Prevention (CDC), birth defects affects every 1 in 33 babies born in the US. On the other hand, chromosomal abnormalities such as Down syndrome affects 1 in 691 babies born in the US, as per the CDC’s data in 2017.

    On the other hand, a survey conducted by John Hopkins University in 2015 states that approximately 20-30% of infant deaths are a result of genetic disorders. Some of the major genetically determined metabolic diseases include sickle cell anemia, phenylketonuria, thalassemia, and others. Down syndrome is the most common chromosomal disorder that affects around 6000 babies in the US, according to the CDC’s statistics. Moreover, according to a report published by Stanford’s Children Health in 2018, sickle cell anemia occurs in almost 1 out 365 black African-American births. Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.


    Product -Based Insights

    In terms of product, the global prenatal and newborn genetic testing market is segmented into screening and diagnostics. In 2018, the screening segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

    Global Prenatal and Newborn Genetic Testing Market, by Product– 2018 and 2027
    Global Prenatal and Newborn Genetic Testing Market, by Product– 2018 and 2027

    Get more information on this report :



    Disease Indication-Based Insights

    In terms of disease indication, the global prenatal and newborn genetic testing market is segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria and other diseases. In 2018, the down syndrome segment held largest share of the market. However, the cystic fibrosis segment is expected to register the highest CAGR during the forecast period.

    End User-Based Insights

    In terms of end user, the global prenatal and newborn genetic testing market is segmented into hospitals & clinics, diagnostic centers and other end user. The hospitals and clinics segment held the largest share of the market in 2018. However, the diagnostics segment is estimated to grow at the fastest rate during the forecast period.

    Strategic Insights

    The global prenatal and newborn genetic testing market players are adopting the product launches, partnerships, and acquisitions to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

    Global Prenatal and Newborn Genetic Testing Market – by Product

    • Diagnostic
    • Spectrophotometer
    • Polymerase Chain Reaction
    • Fluorescence in-situ Hybridization
    • Array-Comparative Genomic Hybridization
    • Screening
    • Maternal Serum Screening
    • Chronic Villus Sampling
    • Amniocentesis
    • Non-invasive Prenatal Testing

    Global Prenatal and Newborn Genetic Testing Market – by Disease Indication

    • Cystic Fibrosis
    • Sickle Cell Anemia
    • Down Syndrome
    • Phenylketonuria
    • Other Diseases

    Global Prenatal and Newborn Genetic Testing Market – by End- User

    • Hospitals & Clinics
    • Diagnostic Centres
    • Other End Users

    Global Prenatal and Newborn Genetic Testing Market – by Geography

    • North America

      • US
      • Canada
      • Mexico
    • Europe

      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)

      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East & Africa (MEA)

      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South America and Central America (SCAM)

      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Abbott
    • Quest Diagnostics Incorporated
    • Ravgen
    • Bio-Rad Laboratories, Inc.,
    • Illumina, Inc.
    • F. Hoffmann La-Roche Ltd.
    • Qiagen
    • Berry Gene
    • PerkinElmer, Inc.
    • Natera, Inc.
    • Laboratory Corporation of America Holdings (Sequenom)

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Prenatal and Newborn Genetic Testing Market – By Product

    1.3.2 Global Prenatal and Newborn Genetic Testing Market – By Disease Indication

    1.3.3 Global Prenatal and Newborn Genetic Testing Market – By End User

    1.3.4 Global Prenatal and Newborn Genetic Testing Market – By Geography

    2. Global Prenatal And Newborn Genetic Testing Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Global Prenatal And Newborn Genetic Testing– Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East & Africa– PEST Analysis

    4.2.5 South & Central America – PEST Analysis

    5. Global Prenatal And Newborn Genetic Testing Market – Key Industry Dynamics

    5.1 Key Market Drivers

    5.1.1 High Prevalence of Genetic Diseases in Infants

    5.1.2 Government Support to Promote Prenatal and Newborn Testing

    5.1.3 Increasing Birth Rate

    5.2 Key Market Restraints

    5.2.1 Risks Associated with Prenatal Testing

    5.3 Key Market Opportunities

    5.3.1 Emerging Markets in Developing Countries

    5.4 Future Trends

    5.4.1 Digital Microfluidics Poses a New Opportunity Area for the Newborn Screening Market

    5.5 Impact Analysis

    6. Prenatal And Newborn Genetic Testing Market – Global Analysis

    6.1 Global Prenatal And Newborn Genetic Testing Market Revenue Forecasts And Analysis

    6.2 Global Prenatal And Newborn Genetic Testing Market, By Geography - Forecasts And Analysis

    6.3 Performance of Key Players

    6.3.1 F. Hoffmann La-Roche Ltd.

    6.3.2 Laboratory Corporation of America Holdings (Sequenom)

    6.3.3 PerkinElmer, Inc.

    7. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Product

    7.1 Overview

    7.2 Global Prenatal and Newborn Genetic Testing Market Share By Product 2018 & 2027 (%)

    7.3 Diagnostic Market

    7.3.1 Overview

    7.3.2 Diagnostic Market Revenue and Forecast to 2027 (US$ Mn)

    7.3.3 Spectrophotometer Market

    7.3.3.1 Overview

    7.3.3.2 Spectrophotometer Market Revenue and Forecast to 2027 (US$ Mn)

    7.3.4 Polymerase Chain Reaction Market

    7.3.4.1 Overview

    7.3.4.2 Polymerase Chain Reaction Market Revenue and Forecast to 2027 (US$ Mn)

    7.3.5 Fluorescence in-situ Hybridization Market

    7.3.5.1 Overview

    7.3.5.2 Fluorescence in-situ Hybridization Market Revenue and Forecast to 2027 (US$ Mn)

    7.3.6 Array Comparative Genomic Hybridization Market

    7.3.6.1 Overview

    7.3.6.2 Array Comparative Genomic Hybridization Market Revenue and Forecast to 2027 (US$ Mn)

    7.4 Screening Market

    7.4.1 Overview

    7.4.2 Screening Market Revenue and Forecast to 2027 (US$ Mn)

    7.4.3 Maternal Serum Screening Market

    7.4.3.1 Overview

    7.4.3.2 Maternal Serum Screening Market Revenue and Forecast to 2027 (US$ Mn)

    7.4.4 Chorionic Villus Sampling Market

    7.4.4.1 Overview

    7.4.4.2 Chorionic Villus Sampling Market Revenue and Forecast to 2027 (US$ Mn)

    7.4.5 Amniocentesis Market

    7.4.5.1 Overview

    7.4.5.2 Amniocentesis Market Revenue and Forecast to 2027 (US$ Mn)

    7.4.6 Non-Invasive Prenatal Testing Market

    7.4.6.1 Overview

    7.4.6.2 Non-Invasive Prenatal Testing Market Revenue and Forecast to 2027 (US$ Mn)

    8. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – Disease Indication

    8.1 Overview

    8.2 Global Prenatal and Newborn Genetic Testing Market Share By Disease Indication 2018 & 2027 (%)

    8.3 Cystic Fibrosis

    8.3.1 Overview

    8.3.2 Cystic Fibrosis Market Revenue and Forecast to 2027 (US$ Mn)

    8.4 Sickle Cell Anemia

    8.4.1 Overview

    8.4.2 Sickle Cell Anemia Market Revenue and Forecast to 2027 (US$ Mn)

    8.5 Down Syndrome

    8.5.1 Overview

    8.5.2 Downs Syndrome Market Revenue and Forecast to 2027 (US$ Mn)

    8.6 Phenylketonuria

    8.6.1 Overview

    8.6.2 Phenylketonuria Market Revenue and Forecast to 2027 (US$ Mn)

    8.7 Other Diseases

    8.7.1 Overview

    8.7.2 Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

    9. Prenatal And Newborn Genetic Testing Market Analysis And Forecasts To 2027 – End User

    9.1 Overview

    9.2 Global Prenatal And Newborn Genetic Testing Market Share By End User 2018 & 2027 (%)

    9.3 Hospitals & Clinics

    9.3.1 Overview

    9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

    9.4 Diagnostics Centers

    9.4.1 Overview

    9.4.2 Diagnostics Centers Market Revenue and Forecast to 2027 (US$ Mn)

    9.5 Other End Users

    9.5.1 Overview

    9.5.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)

    10. Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 – Geographical Analysis

    10.1 North America Prenatal And Newborn Genetic Testing Market

    10.1.1 Overview

    10.1.2 North America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.1.3 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.1.3.1 North America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.1.3.2 North America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.1.4 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.1.5 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.2 North America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Country (%)

    10.3 US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    10.3.1 US Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.3.1.1 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.3.1.1.1 US Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.3.1.1.2 US Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.3.1.2 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.3.1.3 US Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.4 Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    10.4.1 Canada Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.4.1.1 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.4.1.1.1 Canada Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.4.1.1.2 Canada Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.4.1.2 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.4.1.3 Canada Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.5 Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    10.5.1 Mexico Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.5.1.1 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.5.1.1.1 Mexico Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.5.1.1.2 Mexico Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.5.1.2 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.5.1.3 Mexico Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.6 Europe Prenatal And Newborn Genetic Testing Market

    10.6.1 Overview

    10.6.2 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)

    10.6.3 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.6.3.1 Europe Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.3.2 Europe Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.4 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.6.5 Europe Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.6.6 Europe Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    10.6.7 Germany Prenatal and Newborn Genetic Testing Market

    10.6.7.1 Germany Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.6.7.2 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.6.7.2.1 Germany Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.7.2.2 Germany Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.7.3 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.6.7.4 Germany Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.6.8 UK Prenatal and Newborn Genetic Testing Market

    10.6.8.1 UK Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.6.8.2 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.6.8.2.1 UK Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.8.2.2 UK Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.8.3 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.6.8.4 UK Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.6.9 France Prenatal and Newborn Genetic Testing Market

    10.6.9.1 France Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.6.9.2 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.6.9.2.1 France Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.9.2.2 France Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.9.3 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.6.9.4 France Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.6.10 Spain Prenatal and Newborn Genetic Testing Market

    10.6.10.1 Spain Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.6.10.2 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.6.10.2.1 Spain Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.10.2.2 Spain Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.10.3 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.6.10.4 Spain Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.6.11 Italy Prenatal and Newborn Genetic Testing Market

    10.6.11.1 Italy Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.6.11.2 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.6.11.2.1 Italy Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.11.2.2 Italy Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.6.11.3 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.6.11.4 Italy Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.7 Asia Pacific Prenatal And Newborn Genetic Testing Market

    10.7.1 Overview

    10.7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.7.3 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.7.3.1 Asia Pacific Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.7.3.2 Asia Pacific Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.7.4 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.7.5 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.8 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    10.8.1 China Prenatal And Newborn Genetic Testing Market

    10.8.1.1 China Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.8.1.2 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.8.1.2.1 China Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.1.2.2 China Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.1.3 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.8.1.4 China Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.8.2 Japan Prenatal And New born Genetic Testing Market

    10.8.2.1 Japan Prenatal And New Born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.8.2.2 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.8.2.2.1 Japan Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.2.2.2 Japan Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.2.3 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.8.2.4 Japan Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.8.3 India Prenatal And New born Genetic Testing Market

    10.8.3.1 India Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.8.3.2 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.8.3.2.1 India Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.3.2.2 India Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.3.3 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.8.3.4 India Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.8.4 Australia Prenatal And New Born Genetic Testing Market

    10.8.4.1 Australia Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.8.4.2 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.8.4.2.1 Australia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.4.2.2 Australia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.4.3 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.8.4.4 Australia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.8.5 South Korea Prenatal And Newborn Genetic Testing Market

    10.8.5.1 South Korea Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.8.5.2 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.8.5.2.1 South Korea Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.5.2.2 South Korea Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.8.5.3 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.8.5.4 South Korea Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.9 Middle East And Africa Prenatal And Newborn Genetic Testing Market

    10.9.1 Overview

    10.9.2 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.9.2.1 Middle East & Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.9.2.2 Middle East & Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.9.3 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.9.4 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.10 Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    10.10.1 UAE Prenatal And New born Genetic Testing Market

    10.10.1.1 UAE Prenatal And Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.10.1.2 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.10.1.2.1 UAE Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.10.1.2.2 UAE Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.10.1.3 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.10.1.4 UAE Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.10.2 Saudi Arabia Prenatal And Newborn Genetic Testing Market

    10.10.2.1 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.10.2.2 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.10.2.2.1 Saudi Arabia Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.10.2.2.2 Saudi Arabia Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.10.2.3 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.10.2.4 Saudi Arabia Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.10.3 South Africa Prenatal And Newborn Genetic Testing Market

    10.10.3.1 South Africa Prenatal And New born Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.10.3.2 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.10.3.2.1 South Africa Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.10.3.2.2 South Africa Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.10.3.3 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.10.3.4 South Africa Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.11 South And Central America Prenatal And Newborn Genetic Testing Market

    10.11.1 Overview

    10.11.2 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027 (US$ Mn)

    10.11.3 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.11.3.1 South and Central America Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.11.3.2 South and Central America Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.11.4 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.11.5 South and Central America Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.11.6 South and Central America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    10.11.7 Brazil Prenatal and Newborn Genetic Testing Market

    10.11.7.1 Brazil Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.11.7.2 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.11.7.2.1 Brazil Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.11.7.2.2 Brazil Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.11.7.3 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.11.7.4 Brazil Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    10.11.8 Argentina Prenatal and Newborn Genetic Testing Market

    10.11.8.1 Argentina Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027 (US$ Mn)

    10.11.8.2 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Product (US$ Mn)

    10.11.8.2.1 Argentina Screening Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.11.8.2.2 Argentina Diagnostics Market Revenue And Forecasts to 2027, By Type (US$ Mn)

    10.11.8.3 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

    10.11.8.4 Argentina Prenatal and Newborn Genetic Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

    11. Prenatal And Newborn Genetic Testing Market – Industry Landscape

    11.1 Overview

    11.2 Comparative Company Analysis

    11.3 Growth Strategies Done by the Companies in the Market, (%)

    11.4 Organic Developments

    11.4.1 Overview

    11.5 Inorganic Developments

    11.5.1 Overview

    12. Prenatal And Newborn Genetic Testing Market–Key Company Profiles

    12.1 Abbott

    12.1.1 Key Facts

    12.1.2 Business Description

    12.1.3 Financial Overview

    12.1.4 Product Portfolio

    12.1.5 SWOT Analysis

    12.1.6 Key Developments

    12.2 Quest Diagnostics Incorporated

    12.2.1 Key Facts

    12.2.2 Business Description

    12.2.3 Financial Overview

    12.2.4 Product Portfolio

    12.2.5 SWOT Analysis

    12.2.6 Key Developments

    12.3 Ravgen

    12.3.1 Key Facts

    12.3.2 Business Description

    12.3.3 Financial Overview

    12.3.4 Product Portfolio

    12.3.5 SWOT Analysis

    12.3.6 Key Developments

    12.4 F. Hoffmann-La Roche Ltd.

    12.4.1 Key Facts

    12.4.2 Business Description

    12.4.3 Financial Overview

    12.4.4 Product Portfolio

    12.4.5 SWOT Analysis

    12.4.6 Key Developments

    12.5 Qiagen N.V.

    12.5.1 Key Facts

    12.5.2 Business Description

    12.5.3 Financial Overview

    12.5.4 Product Portfolio

    12.5.5 SWOT Analysis

    12.5.6 Key Developments

    12.6 Bio-Rad Laboratories, Inc.

    12.6.1 Key Facts

    12.6.2 Business Description

    12.6.3 Financial Information

    12.6.4 Product Portfolio

    12.6.5 SWOT Analysis

    12.6.6 Key Developments

    12.7 Berry Gene

    12.7.1 Key Facts

    12.7.2 Business Description

    12.7.3 Financial Overview

    12.7.4 Product Portfolio

    12.7.5 SWOT Analysis

    12.7.6 Key Developments

    12.8 PerkinElmer, Inc.

    12.8.1 Key Facts

    12.8.2 Business Description

    12.8.3 Financial Overview

    12.8.4 Product Portfolio

    12.8.5 SWOT Analysis

    12.8.6 Key Developments

    12.9 Natera, Inc.

    12.9.1 Key Facts

    12.9.2 Business Description

    12.9.3 Financial Overview

    12.9.4 Product Portfolio

    12.9.5 SWOT Analysis

    12.9.6 Key Developments

    12.10 Laboratory Corporation Of America Holdings (Sequenom)

    12.10.1 Key Facts

    12.10.2 Business Description

    12.10.3 Financial Overview

    12.10.4 Product Portfolio

    12.10.5 SWOT Analysis

    12.10.6 Key Developments

    12.11 Illumina, Inc.

    12.11.1 Key Facts

    12.11.2 Business Description

    12.11.3 Financial Overview

    12.11.4 Product Portfolio

    12.11.5 SWOT Analysis

    12.11.6 Key Developments

    13. Appendix

    13.1 About The Insight Partners

    13.2 Glossary Of Terms


    LIST OF TABLES

    Table 1. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 2. North America Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 3. North America Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 4. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 5. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 6. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 7. US Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 8. US Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 9. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 10. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 11. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 12. Canada Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 13. Canada Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 14. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 15. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 16. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 17. Mexico Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 18. Mexico Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 19. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 20. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 21. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 22. Europe Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 23. Europe Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 24. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 25. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 26. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 27. Germany Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 28. Germany Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 29. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 30. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 31. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 32. UK Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 33. UK Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 34. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 35. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 36. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 37. France Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 38. France Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 39. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 40. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 41. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 42. Spain Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 43. Spain Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 44. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 45. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 46. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 47. Italy Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 48. Italy Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 49. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 50. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 51. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 52. Asia Pacific Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 53. Asia Pacific Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 54. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 55. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 56. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 57. China Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 58. China Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 59. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 60. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 61. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 62. Japan Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 63. Japan Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 64. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 65. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 66. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 67. India Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 68. India Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 69. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 70. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 71. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 72. Australia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 73. Australia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 74. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 75. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 76. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 77. South Korea Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 78. South Korea Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 79. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 80. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 81. Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 82. Middle East & Africa Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 83. Middle East & Africa Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 84. Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 85. Middle East & Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 86. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 87. UAE Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 88. UAE Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 89. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 90. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 91. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 92. Saudi Arabia Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 93. Saudi Arabia Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 94. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 95. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 96. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 97. South Africa Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 98. South Africa Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 99. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 100. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 101. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 102. South And Central America Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 103. South And Central America Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 104. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 105. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 106. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 107. Brazil Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 108. Brazil Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 109. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 110. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 111. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Product (US$ Mn)

    Table 112. Argentina Screening Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 113. Argentina Diagnostics Market Revenue And Forecasts To 2027, By Type (US$ Mn)

    Table 114. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

    Table 115. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)

    Table 116. Organic Developments Done By Companies

    Table 117. Inorganic Developments Done By Companies

    Table 118. Glossary Of Terms, Prenatal And Newborn Genetic Testing Market

    LIST OF FIGURES

    Figure 1. Prenatal And Newborn Genetic Testing Market Segmentation

    Figure 2. Prenatal And Newborn Genetic Testing Segmentation, By Region

    Figure 3. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue (US$ Mn), 2018 & 2027

    Figure 4. Global Prenatal And Newborn Genetic Testing Market By Product, Market Share (%), 2018

    Figure 5. Global Prenatal And Newborn Genetic Testing Market By Disease Indication, Market Share (%), 2018

    Figure 6. Global Prenatal And Newborn Genetic Testing Market By End User, Market Share (%), 2018

    Figure 7. North America PEST Analysis

    Figure 8. Europe PEST Analysis

    Figure 9. Asia Pacific PEST Analysis

    Figure 10. Middle East & Africa PEST Analysis

    Figure 11. South & Central America PEST Analysis

    Figure 12. Prenatal And Newborn Genetic Testing Market Impact Analysis of Driver And Restraints

    Figure 13. Global Prenatal And Newborn Genetic Testing Market – Revenue Forecasts And Analysis – 2018- 2027

    Figure 14. Global Prenatal And Newborn Genetic Testing Market – By Geography Forecasts And Analysis – 2018- 2027

    Figure 15. Global Prenatal and Newborn Genetic Testing Market Share By Product 2018 & 2027 (%)

    Figure 16. Diagnostic Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 17. Spectrophotometer Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 18. Polymerase Chain Reaction Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 19. Fluorescence In-Situ Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 20. Array Comparative Genomic Hybridization Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 21. Screening Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 22. Maternal Serum Screening Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 23. Chorionic Villus Sampling Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 24. Amniocentesis Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 25. Non-Invasive Prenatal Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 26. Global Prenatal and Newborn Genetic Testing Market Share By Disease Indication 2018 & 2027 (%)

    Figure 27. Cystic Fibrosis Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 28. Sickle Cell Anemia Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 29. Downs Syndrome Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 30. Phenylketonuria Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 31. Other Diseases Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 32. Global Prenatal and Newborn Genetic Testing Market Share By End User 2018 & 2027 (%)

    Figure 33. Global Hospitals & Clinics Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 34. Diagnostics Centers Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 35. Global Other End User Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 36. North America Prenatal And Newborn Genetic Testing Market REVENUE Overview, By Country, 2018 (US$ MN)

    Figure 37. North America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 38. North America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    Figure 39. US Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 40. Canada Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 41. Mexico Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 42. Europe Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)

    Figure 43. Europe Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 44. Europe Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    Figure 45. Germany Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 46. UK Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 47. France Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 48. Spain Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 49. Italy Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 50. Asia Pacific Prenatal And Newborn Genetic Testing Market REVENUE Overview, By Country, 2018 (US$ MN)

    Figure 51. Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 52. Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    Figure 53. China Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 54. Japan Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 55. India Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 56. Australia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 57. South Korea Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 58. Middle East And Africa Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)

    Figure 59. Middle East & Africa Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    Figure 60. UAE Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 61. Saudi Arabia Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 62. South Africa Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 63. South And Central America Prenatal And Newborn Genetic Testing Market Revenue Overview, By Country (2018) (US$ Mn)

    Figure 64. South And Central America Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 65. South and Central America Prenatal and Newborn Genetic Testing Market Revenue and Forecasts to 2027, By Country (%)

    Figure 66. Brazil Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 67. Argentina Prenatal And Newborn Genetic Testing Market Revenue And Forecasts To 2027 (US$ Mn)

    Figure 68. Comparative Company Analysis

    Figure 69. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies

    1. Abbott
    2. Quest Diagnostics Incorporated
    3. Ravgen
    4. Bio-Rad Laboratories, Inc.
    5. Illumina, Inc.
    6. F. Hoffmann La-Roche Ltd.
    7. Qiagen
    8. Berry Gene
    9. PerkinElmer, Inc.
    10. Natera, Inc.
    11. Laboratory Corporation of America Holdings (Sequenom)
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the prenatal and newborn genetic testing market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global prenatal and newborn genetic testing market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPBT00002550
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Pricing
    • $3000
    • $4550 $3640
    • $6550 $5240
    • $8550 $6840

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst